Quantitative assessment of neurologic deficits in a chronic progressive murine model of CNS demyelination

Dorian B. McGavern, Laurie Zoecklein, Kristen M. Drescher, Moses Rodriguez

Research output: Contribution to journalArticle

60 Citations (Scopus)

Abstract

The precise factors involved in the development of a progressive motor dysfunction, a hallmark of immune-mediated demyelinating diseases such as multiple sclerosis, are not well defined. The ability to identify neurologic deficits that result in impaired motor performance early in disease may allow for the identification of therapeutic interventions that slow or eliminate the progression toward a permanent dysfunction. Here we describe the use of three objective, quantitative functional assays (spontaneous activity box, rotarod, and footprint analysis) to detect early neurologic deficits following the initiation of a demyelinating disease with Theiler's murine encephalomyelitis virus (TMEV). The results show that the assays are capable of revealing neurologic deficits at the early stages of the demyelinating disease process. These findings are the first to objectively characterize neurologic function in an animal model of progressive CNS demyelination.

Original languageEnglish
Pages (from-to)171-181
Number of pages11
JournalExperimental Neurology
Volume158
Issue number1
DOIs
StatePublished - Jul 1999
Externally publishedYes

Fingerprint

Demyelinating Diseases
Neurologic Manifestations
Theilovirus
Nervous System
Multiple Sclerosis
Animal Models
Therapeutics

All Science Journal Classification (ASJC) codes

  • Neurology
  • Neuroscience(all)

Cite this

Quantitative assessment of neurologic deficits in a chronic progressive murine model of CNS demyelination. / McGavern, Dorian B.; Zoecklein, Laurie; Drescher, Kristen M.; Rodriguez, Moses.

In: Experimental Neurology, Vol. 158, No. 1, 07.1999, p. 171-181.

Research output: Contribution to journalArticle

McGavern, Dorian B. ; Zoecklein, Laurie ; Drescher, Kristen M. ; Rodriguez, Moses. / Quantitative assessment of neurologic deficits in a chronic progressive murine model of CNS demyelination. In: Experimental Neurology. 1999 ; Vol. 158, No. 1. pp. 171-181.
@article{94a45278d9a441a98dbe3a6062998a37,
title = "Quantitative assessment of neurologic deficits in a chronic progressive murine model of CNS demyelination",
abstract = "The precise factors involved in the development of a progressive motor dysfunction, a hallmark of immune-mediated demyelinating diseases such as multiple sclerosis, are not well defined. The ability to identify neurologic deficits that result in impaired motor performance early in disease may allow for the identification of therapeutic interventions that slow or eliminate the progression toward a permanent dysfunction. Here we describe the use of three objective, quantitative functional assays (spontaneous activity box, rotarod, and footprint analysis) to detect early neurologic deficits following the initiation of a demyelinating disease with Theiler's murine encephalomyelitis virus (TMEV). The results show that the assays are capable of revealing neurologic deficits at the early stages of the demyelinating disease process. These findings are the first to objectively characterize neurologic function in an animal model of progressive CNS demyelination.",
author = "McGavern, {Dorian B.} and Laurie Zoecklein and Drescher, {Kristen M.} and Moses Rodriguez",
year = "1999",
month = "7",
doi = "10.1006/exnr.1999.7082",
language = "English",
volume = "158",
pages = "171--181",
journal = "Experimental Neurology",
issn = "0014-4886",
publisher = "Academic Press Inc.",
number = "1",

}

TY - JOUR

T1 - Quantitative assessment of neurologic deficits in a chronic progressive murine model of CNS demyelination

AU - McGavern, Dorian B.

AU - Zoecklein, Laurie

AU - Drescher, Kristen M.

AU - Rodriguez, Moses

PY - 1999/7

Y1 - 1999/7

N2 - The precise factors involved in the development of a progressive motor dysfunction, a hallmark of immune-mediated demyelinating diseases such as multiple sclerosis, are not well defined. The ability to identify neurologic deficits that result in impaired motor performance early in disease may allow for the identification of therapeutic interventions that slow or eliminate the progression toward a permanent dysfunction. Here we describe the use of three objective, quantitative functional assays (spontaneous activity box, rotarod, and footprint analysis) to detect early neurologic deficits following the initiation of a demyelinating disease with Theiler's murine encephalomyelitis virus (TMEV). The results show that the assays are capable of revealing neurologic deficits at the early stages of the demyelinating disease process. These findings are the first to objectively characterize neurologic function in an animal model of progressive CNS demyelination.

AB - The precise factors involved in the development of a progressive motor dysfunction, a hallmark of immune-mediated demyelinating diseases such as multiple sclerosis, are not well defined. The ability to identify neurologic deficits that result in impaired motor performance early in disease may allow for the identification of therapeutic interventions that slow or eliminate the progression toward a permanent dysfunction. Here we describe the use of three objective, quantitative functional assays (spontaneous activity box, rotarod, and footprint analysis) to detect early neurologic deficits following the initiation of a demyelinating disease with Theiler's murine encephalomyelitis virus (TMEV). The results show that the assays are capable of revealing neurologic deficits at the early stages of the demyelinating disease process. These findings are the first to objectively characterize neurologic function in an animal model of progressive CNS demyelination.

UR - http://www.scopus.com/inward/record.url?scp=0032868603&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032868603&partnerID=8YFLogxK

U2 - 10.1006/exnr.1999.7082

DO - 10.1006/exnr.1999.7082

M3 - Article

C2 - 10448429

AN - SCOPUS:0032868603

VL - 158

SP - 171

EP - 181

JO - Experimental Neurology

JF - Experimental Neurology

SN - 0014-4886

IS - 1

ER -